Literature DB >> 30702587

Catheter ablation of a right posterior accessory pathway in a patient with left ventricular noncompaction: A case report.

Bianca Olivia Cojan-Minzat1, Paul-Mihai Boarescu2, Gabriel Cismaru2, Radu Rosu2, Carmen Cionca3, Dana Pop2, Dumitru Zdrenghea2, Lucia Agoston-Coldea1,3.   

Abstract

RTIONALE: Left ventricular noncompaction (LVNC) is a genetic cardiomyopathy characterized by the presence of a thin compacted layer of myocardium and a spongy subendocardial layer with trabeculations and recesses. LVNC associated Wolf-Parkinson-White syndrome is very rare. PATIENT CONCERNS: A 32-year-old male presented with short episodes of palpitations and a syncope 6 months before his hospitalization. DIAGNOSIS: His ECG revealed the presence of a right posterior accessory pathway. Echocardiography identified trabeculations of the septal, apical, and lateral wall of the left ventricle, consistent with left ventricular noncompaction. Cardiac MRI confirmed the diagnosis, as the ratio between the noncompacted and compacted myocardial layer was 2.3.
INTERVENTIONS: The electrophysiological study revealed a malignant right posterior accessory pathway. Catheter ablation was successfully performed at the level of posterior tricuspid annulus. Programmed ventricular stimulation could not induce any arrhythmia at the end of the procedure. OUTCOMES: During 15 months of follow-up, the patient presented no more episodes of palpitations or syncope. LESSONS: Left ventricular noncompaction with right accessory pathway is a rare association with genetic basis and gives a higher risk of sudden cardiac death. Catheter ablation of the accessory pathway is a valuable way of treatment in this category of patients, lowering the risk of sudden cardiac death.

Entities:  

Mesh:

Year:  2019        PMID: 30702587      PMCID: PMC6380869          DOI: 10.1097/MD.0000000000014267

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


Introduction

Left ventricular noncompaction (LVNC) is a genetic cardiomyopathy characterized by a modified structure of the myocardium, with a thin epicardial and a noncompacted, thickened endocardial layer.[ It results from incomplete embryogenesis[ and can be associated with other cardiac abnormalities and neuromuscular disorders.[ Patients with the disease can present with heart failure, arrhythmias or thromboembolic events.[ We describe the case of a patient with LVNC and a right accessory pathway that successfully underwent catheter ablation by radiofrequency. The patient provided informed consent for the publication of the case.

Case report

A 32-year-old male with dilated cardiomyopathy was hospitalized for recurring episodes of palpitations lasting <1 minute. Six months prior to the hospitalization, the patient had a syncope. He had no family history of sudden cardiac death, but has a 30-year-old brother with dilated cardiomyopathy. The physical examination revealed a grade II apical systolic murmur, and was otherwise normal, without any sign of left or right heart failure. The twelve-lead ECG showed sinus rhythm with a heart rate of 70 beats per minute, short PR interval (80) ms and delta wave (Fig. 1) suggesting a right posterior accessory pathway. Echocardiography revealed a dilated left ventricle (LV) with a low ejection fraction of 30%. Multiple trabeculations separated by deep recesses were present on the septal, apical and lateral wall of the LV, consistent with LVNC (Fig. 2). Cardiac magnetic resonance imaging and computed tomography confirmed LVNC. The ratio between the noncompacted and compacted layers in diastole was above 2.3 (epicardial noncompacted layer—17 mm, endocardial compacted layer—7 mm) and there was no evidence of LV thrombus (Fig. 3). Contrast-enhanced computed tomography was also performed to exclude any coronary abnormalities, as the origin of the left main coronary artery was visible on echocardiography and appeared enlarged. However, the origin and course of the coronary arteries was normal. Neither the 24 hour Holter ECG nor the exercise stress test revealed any sustained supraventricular or ventricular arrhythmia.
Figure 1

Twelve-lead electrocardiogram at baseline shows a short PR interval of 80 ms and negative delta waves in lead II, III, aVF, andV1, consistent with a right posterior accessory pathway. PR interval = interval between the P wave and th QRS complex.

Figure 2

Two-dimensional echocardiography showing a dilated left ventricle with low ejection fraction and trabeculations separated by recesses of the anterior, septal, and lateral LV walls. LV = left ventricle.

Figure 3

Cardiac magnetic resonance imaging (A–C) and computer tomography (D–F) short axis and longitudinal axis images showing trabeculations of the anterior, lateral and septal LV walls; the thickness of the noncompacted layer is 17 mm, while the thicnkess of the compacted layer is 7 mm, yielding a ratio between layers of 2.4; there is no visible thrombus in the LV. LV = left ventricle,

Twelve-lead electrocardiogram at baseline shows a short PR interval of 80 ms and negative delta waves in lead II, III, aVF, andV1, consistent with a right posterior accessory pathway. PR interval = interval between the P wave and th QRS complex. Two-dimensional echocardiography showing a dilated left ventricle with low ejection fraction and trabeculations separated by recesses of the anterior, septal, and lateral LV walls. LV = left ventricle. Cardiac magnetic resonance imaging (A–C) and computer tomography (D–F) short axis and longitudinal axis images showing trabeculations of the anterior, lateral and septal LV walls; the thickness of the noncompacted layer is 17 mm, while the thicnkess of the compacted layer is 7 mm, yielding a ratio between layers of 2.4; there is no visible thrombus in the LV. LV = left ventricle, Considering the history of syncope and the ECG pattern consistent with the presence of an accessory pathway, an electrophysiological study was performed. A negative HV interval of-20 ms was documented, suggesting an accessory pathway which had a short refractory period (<230 ms) (Fig. 4). Mapping of the tricuspid annulus revealed the localization of the pathway at the level of the posterior ring. Catheter ablation at this level abolished conduction through the accessory pathway (Fig. 5). The postablation ECG without delta wave is shown in Figure 6. Programmed ventricular stimulation was also performed, with aggressive stimulation to 180 ms using 3 extra stimuli from the RV apex and RVOT, before and after adrenaline infusion. We could not induce any arrhythmia.
Figure 4

The electrophysiological study yields a negative −20 ms HV interval, consistent with the presence of an accessory pathway with short refractory period (<230 ms). HV = his-ventricular interval.

Figure 5

Catheter mapping at the level of the tricuspid annulus identified as pot where the atrial electrogram was fused with the ventricular electrogram. Catheter ablation at this level abolished the conduction through the accessory pathway.

Figure 6

Twelve-lead ECG after catheter ablation shows normal PR interval with absent delta wave. Negative T waves in the inferior leads suggest T-wave memory after successful catheter ablation of the accessory pathway.

The electrophysiological study yields a negative −20 ms HV interval, consistent with the presence of an accessory pathway with short refractory period (<230 ms). HV = his-ventricular interval. Catheter mapping at the level of the tricuspid annulus identified as pot where the atrial electrogram was fused with the ventricular electrogram. Catheter ablation at this level abolished the conduction through the accessory pathway. Twelve-lead ECG after catheter ablation shows normal PR interval with absent delta wave. Negative T waves in the inferior leads suggest T-wave memory after successful catheter ablation of the accessory pathway. Considering the underlying myocardial disease, the severely impaired systolic function and history of syncope, we decided to proceed with an implanted cardioverter-defibrillator (ICD). The patient was long-term anticoagulated to prevent peripheral and cerebral embolism. He received beta blockers and angiotensin converting enzyme inhibitors for severely impaired LV systolic function.

Discussion

LVNC is thought to be determined by the arrest of the normal process of compaction during intrauterine life, resulting in a spongy aspect of the endocardial ventricular myocardium, with large trabeculations separated by intraventricular recesses.[ Also, in some cases, LVNC is accompanied by the abnormal closure of both annular fibrous tissues, facilitating the formation of accessory pathways. The presence of the WPW syndrome has been reported in 15% of the pediatric population with LVNC,[ and, although rarer, it has also been reported in adults.[ In the currently presented case, the patient has been asymptomatic until the age of 32, when he experienced a syncope, prompting further investigation. The diagnosis of LVNC was made based on the echocardiogram and confirmed by cardiac magnetic resonance imaging, which was previously shown to be superior to echocardiography in diagnosing this condition.[ In our patient, the ratio of the diastolic thickness of the noncompacted to compacted area was 2.4; thus respecting the cardiac magnetic resonance imaging criteria for LVNC described by Petersen et al.[ The ECG pattern consistent with the presence of an accessory pathway justified an electrophysiological study which confirmed the presence of a right posterior accessory pathway with a refractory period of 230 ms. Since the short refractory period (≤ 250 ms) is a known risk factor for potentially life-threatening arrhythmias,[ we proceeded with radiofrequency ablation, which was successfully performed. However, we could not safely assume that the syncope was triggered by arrhythmias associated with the presence of the accessory pathway. In patients with LVNC, ventricular arrhythmias are one of the most frequent causes of death. A previous study on 34 patients with LVNC reported ventricular arrhythmias in 47% of the participants and sudden cardiac death in 35%.[ Although LVNC per se is not an indication for ICD,[ the presence of LV dilatation and severely impaired systolic function[ prompted us to refer the patient for the implantation of an ICD. We discharged the patient on beta-blockers. The decision to anticoagulate was a rather difficult one, considering the conflicting data on the subject. The study by Fazio et al[ did not provide any evidence that LVNC by itself would be a risk factor for thromboembolic events, but Stöllberger et al[ noticed a higher rate of strokes in LVNC patients with severe systolic dysfunction. Considering that our patient had severely impaired LV systolic function, we recommended long-term anticoagulation with coumarins. After a follow-up of 15 months the patient presented no more palpitations or syncope. He presented no episodes of peripheral or cerebral embolism. LVNC is a challenging diagnosis and needs a high suspicion index during echocardiography. Confirmation of the diagnosis is made by cardiac MRI. Association of the disease with an abnormality of the right heart chambers is explained by a common genetic basis. Both LVNC and accessory pathways with short refractory periods have a risk of sudden cardiac death. The risk is even higher in patients that associate both diseases.

Author contributions

Conceptualization: Bianca Olivia Cojan-Minzat, Gabriel Cismaru, Radu Rosu, Lucia Agoston-Coldea. Data curation: Gabriel Cismaru, Bianca Olivia Cojan-Minzat, Paul-Mihai Boarescu, Radu Rosu, Lucia Agoston-Coldea. Investigation: Gabriel Cismaru, Paul-Mihai Boarescu, Radu Rosu, Carmen Cionca, Lucia Agoston-Coldea. Methodology: Gabriel Cismaru, Carmen Cionca, Lucia Agoston-Coldea. Supervision: Gabriel Cismaru, Dana Pop, Lucia Agoston-Coldea. Validation: Dumitru Zdrenghea, Dana Pop, Lucia Agoton-Coldea. Writing – original draft: Gabriel Cismaru, Bianca Olivia Cojan-Minzat, Paul-Mihai Boarescu, Lucia Agoston-Coldea. Writing – review & editing: Gabriel Cismaru, Paul-Mihai Boarescu, Radu Rosu, Dana Pop, Dumitru Zdrenghea, Lucia Agoston-Coldea.
  13 in total

1.  Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis.

Authors:  E N Oechslin; C H Attenhofer Jost; J R Rojas; P A Kaufmann; R Jenni
Journal:  J Am Coll Cardiol       Date:  2000-08       Impact factor: 24.094

Review 2.  Noncompaction of the ventricular myocardium.

Authors:  Brian C Weiford; Vijay D Subbarao; Kevin M Mulhern
Journal:  Circulation       Date:  2004-06-22       Impact factor: 29.690

Review 3.  Isolated ventricular non-compaction of the myocardium in adults.

Authors:  R Jenni; E N Oechslin; B van der Loo
Journal:  Heart       Date:  2006-05-02       Impact factor: 5.994

4.  Implantable cardioverter-defibrillators in patients with left ventricular noncompaction.

Authors:  Richard Kobza; Rolf Jenni; Paul Erne; Erwin Oechslin; Firat Duru
Journal:  Pacing Clin Electrophysiol       Date:  2008-04       Impact factor: 1.976

5.  Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging.

Authors:  Steffen E Petersen; Joseph B Selvanayagam; Frank Wiesmann; Matthew D Robson; Jane M Francis; Robert H Anderson; Hugh Watkins; Stefan Neubauer
Journal:  J Am Coll Cardiol       Date:  2005-07-05       Impact factor: 24.094

6.  Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy.

Authors:  R Jenni; E Oechslin; J Schneider; C Attenhofer Jost; P A Kaufmann
Journal:  Heart       Date:  2001-12       Impact factor: 5.994

7.  Frequency of stroke and embolism in left ventricular hypertrabeculation/noncompaction.

Authors:  Claudia Stöllberger; Gerhard Blazek; Christoph Dobias; Aileen Hanafin; Christian Wegner; Josef Finsterer
Journal:  Am J Cardiol       Date:  2011-07-23       Impact factor: 2.778

8.  Anticoagulant drugs in noncompaction: a mandatory therapy?

Authors:  Giovanni Fazio; Giovanni Corrado; Elisabetta Zachara; Claudio Rapezzi; Ali K Sulafa; Loredana Sutera; Claudia Stollberger; Luca Sormani; Joseph Finsterer; Abraham Benatar; Gabriele Di Gesaro; Claudia Visconti; Luciana D'angelo; Giuseppina Novo; Maurizio Mongiovi; Yuksel Cavusoglu; Magnus Baumhakel; Fabrizio Drago; Giuseppe Indovina; Filippo Ferrara; Scipione Carerj; Salvatore Pipitone; Salvatore Novo
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2008-11       Impact factor: 2.160

9.  2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).

Authors:  Silvia G Priori; Carina Blomström-Lundqvist; Andrea Mazzanti; Nico Blom; Martin Borggrefe; John Camm; Perry Mark Elliott; Donna Fitzsimons; Robert Hatala; Gerhard Hindricks; Paulus Kirchhof; Keld Kjeldsen; Karl-Heinz Kuck; Antonio Hernandez-Madrid; Nikolaos Nikolaou; Tone M Norekvål; Christian Spaulding; Dirk J Van Veldhuisen
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

10.  Asymptomatic ventricular preexcitation: a long-term prospective follow-up study of 293 adult patients.

Authors:  Vincenzo Santinelli; Andrea Radinovic; Francesco Manguso; Gabriele Vicedomini; Giuseppe Ciconte; Simone Gulletta; Gabriele Paglino; Stefania Sacchi; Simone Sala; Cristiano Ciaccio; Carlo Pappone
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.